Skip to content
Kipps Research LabKipps Research Lab
Kipps Research Lab
Finding the genes that cause blood cancers.
  • Home
  • About Our Research
  • Our Team
  • Publications
  • News
  • Support Our Research
  • Events
 
  • Home
  • About Our Research
  • Our Team
  • Publications
  • News
  • Support Our Research
  • Events

Category Archives: What’s New?

You are here:
  1. Home
  2. Category "What’s New?"

Survival adjusting for crossover: phase 3 study of ibrutinib vs chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma.

Publications, UncategorizedBy m3supportNovember 23, 2017

PubMed

Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Publications, UncategorizedBy m3supportNovember 15, 2017

PubMed

MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia.

Publications, UncategorizedBy m3supportOctober 3, 2017

PubMed

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials.

Publications, UncategorizedBy m3supportJuly 27, 2017

PubMed

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL.

Publications, UncategorizedBy m3supportJune 8, 2017

PubMed

Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.

Publications, UncategorizedBy m3supportMay 19, 2017

PubMed

Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells.

PublicationsBy m3supportMay 3, 2017

PubMed

Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells.

PublicationsBy m3supportMay 3, 2017

PubMed

The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia.

PublicationsBy m3supportApril 18, 2017

PubMed

Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib.

PublicationsBy m3supportApril 10, 2017

PubMed

12345
Kipps Research Lab
© 2016 Kipps Research Lab, Moore's UCSD Cancer Research Center
  • Home
  • About Our Research
  • Our Team
  • Publications
  • News
  • Support Our Research
  • Events
Main